MONDAY, July 7, 2025 (HealthDay News) — The efficacy and safety of currently approved and pipeline medications for moderate-to-severe hidradenitis suppurativa (HS) are compared in a systematic literature review and network meta-analysis published online July 2 in JAMA Dermatology. Amit Garg, M.D., from Northwell in New Hyde Park, New York, and colleagues compared the efficacy, […]
The post Review Compares Efficacy, Safety of Treatments for Hidradenitis Suppurativa first appeared on Physician’s Weekly.
